Literature DB >> 7532541

Enrichment of generated murine osteoclasts.

A Shioi1, F P Ross, S L Teitelbaum.   

Abstract

Biochemical and molecular studies of osteoclasts generally require cells in a reasonable degree of purity. The chicken has been extremely useful in this regard, as abundant avian osteoclasts can be generated in vitro entirely from pure populations of marrow macrophage precursors. Propagation of murine osteoclasts is, in contrast, far less efficient, demanding the presence of stromal cells. The aims of this study were to develop a method by which murine osteoclasts generated in culture, can be effectively enriched while maintaining viability and, to explore the mechanisms by which stromal cells promote murine osteoclast generation and survival. We find that 10(6) fractionated murine marrow cells enriched, for marrow-residing colony-forming units (CFU-cs), yield 3000-4000 tartrate-resistant acid phosphatase (TRAP)-expressing multinucleated giant cells when cultured for 12 days with ST-2 stromal cells. These cells are osteoclasts as evidenced by their ability to "pit" bone slices, resorb radiolabeled bone particles, and generate cyclic AMP in response to calcitonin. Treatment of these generated osteoclast cultures with bacterial collagenase for 2 hours at 37 degrees selectively removes virtually all ST-2 cells, yielding a > 60% pure population of TRAP and calcitonin receptor-expressing cells, 90% of which are viable. These cells continue to respond to calcitonin and survive for 24 hours in the absence of ST-2 cells. We also found that murine osteoclast generation depends upon contact of osteoclast precursors with viable ST-2 cells. Furthermore, the stromal cells secrete macrophage colony-stimulating factor (CSF-1), and the anti-CSF-1 antibody 5A1 inhibits murine osteoclastogenesis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7532541     DOI: 10.1007/bf00299320

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  17 in total

1.  Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells.

Authors:  N Udagawa; N Takahashi; T Akatsu; H Tanaka; T Sasaki; T Nishihara; T Koga; T J Martin; T Suda
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

2.  A comparative study of disaggregated chick and rat osteoclasts in vitro: effects of calcitonin and prostaglandins.

Authors:  T R Arnett; D W Dempster
Journal:  Endocrinology       Date:  1987-02       Impact factor: 4.736

3.  Methods for the purification, assay, characterization and target cell binding of a colony stimulating factor (CSF-1).

Authors:  E R Stanley; L J Guilbert
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

4.  The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells.

Authors:  N Udagawa; N Takahashi; T Akatsu; T Sasaki; A Yamaguchi; H Kodama; T J Martin; T Suda
Journal:  Endocrinology       Date:  1989-10       Impact factor: 4.736

5.  Impairment of macrophage colony-stimulating factor production and lack of resident bone marrow macrophages in the osteopetrotic op/op mouse.

Authors:  R Felix; M G Cecchini; W Hofstetter; P R Elford; A Stutzer; H Fleisch
Journal:  J Bone Miner Res       Date:  1990-07       Impact factor: 6.741

6.  Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse.

Authors:  R Felix; M G Cecchini; H Fleisch
Journal:  Endocrinology       Date:  1990-11       Impact factor: 4.736

7.  Development and characterization of monoclonal antibodies to murine macrophage colony-stimulating factor.

Authors:  B L Lokeshwar; H S Lin
Journal:  J Immunol       Date:  1988-07-15       Impact factor: 5.422

8.  1,25-Dihydroxyvitamin D3 modulates colony-stimulating factor-1 receptor binding by murine bone marrow macrophage precursors.

Authors:  S L Perkins; S L Teitelbaum
Journal:  Endocrinology       Date:  1991-01       Impact factor: 4.736

9.  Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors.

Authors:  S Tanaka; N Takahashi; N Udagawa; T Tamura; T Akatsu; E R Stanley; T Kurokawa; T Suda
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

10.  Isolated osteoclasts resorb the organic and inorganic components of bone.

Authors:  H C Blair; A J Kahn; E C Crouch; J J Jeffrey; S L Teitelbaum
Journal:  J Cell Biol       Date:  1986-04       Impact factor: 10.539

View more
  9 in total

1.  Cloning and characterization of osteoclast precursors from the RAW264.7 cell line.

Authors:  Bethany L V Cuetara; Tania N Crotti; Anthony J O'Donoghue; Kevin P McHugh
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Jul-Aug       Impact factor: 2.416

2.  Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor.

Authors:  Y Abu-Amer; F P Ross; J Edwards; S L Teitelbaum
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

3.  Regulation of sodium-dependent phosphate transport in osteoclasts.

Authors:  A Gupta; X L Guo; U M Alvarez; K A Hruska
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

4.  Osteoclast response to low extracellular sodium and the mechanism of hyponatremia-induced bone loss.

Authors:  Julia Barsony; Yoshihisa Sugimura; Joseph G Verbalis
Journal:  J Biol Chem       Date:  2010-12-06       Impact factor: 5.157

5.  A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo.

Authors:  V W Engleman; G A Nickols; F P Ross; M A Horton; D W Griggs; S L Settle; P G Ruminski; S L Teitelbaum
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

6.  Synergetic activation of outwardly rectifying Cl- currents by hypotonic stress and external Ca2+ in murine osteoclasts.

Authors:  H Sakai; F Nakamura; M Kuno
Journal:  J Physiol       Date:  1999-02-15       Impact factor: 5.182

7.  Tumor necrosis factor-alpha mediates orthopedic implant osteolysis.

Authors:  K D Merkel; J M Erdmann; K P McHugh; Y Abu-Amer; F P Ross; S L Teitelbaum
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

8.  Gelsolin deficiency blocks podosome assembly and produces increased bone mass and strength.

Authors:  M Chellaiah; N Kizer; M Silva; U Alvarez; D Kwiatkowski; K A Hruska
Journal:  J Cell Biol       Date:  2000-02-21       Impact factor: 10.539

9.  Orthogonal targeting of osteoclasts and myeloma cells for radionuclide stimulated dynamic therapy induces multidimensional cell death pathways.

Authors:  Alexander Zheleznyak; Matthew Mixdorf; Lynne Marsala; Julie Prior; Xiaoxia Yang; Grace Cui; Baogang Xu; Steven Fletcher; Francesca Fontana; Gregory Lanza; Samuel Achilefu
Journal:  Theranostics       Date:  2021-06-22       Impact factor: 11.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.